101 related articles for article (PubMed ID: 17803495)
1. The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities.
Deb S; Sohanpal SK; Soni R; Lenôtre L; Unwin G
J Intellect Disabil Res; 2007 Oct; 51(Pt 10):766-77. PubMed ID: 17803495
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review.
Sohanpal SK; Deb S; Thomas C; Soni R; Lenôtre L; Unwin G
J Intellect Disabil Res; 2007 Oct; 51(Pt 10):750-65. PubMed ID: 17803494
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review.
Deb S; Chaplin R; Sohanpal S; Unwin G; Soni R; Lenotre L
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):107-13. PubMed ID: 18197949
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
Deb S; Farmah BK; Arshad E; Deb T; Roy M; Unwin GL
Res Dev Disabil; 2014 Mar; 35(3):711-25. PubMed ID: 24405794
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature.
Deb S; Unwin GL
Curr Opin Psychiatry; 2007 Sep; 20(5):461-6. PubMed ID: 17762588
[TBL] [Abstract][Full Text] [Related]
7. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
8. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: a systematic review.
Unwin GL; Deb S
Res Dev Disabil; 2011; 32(6):2121-33. PubMed ID: 21856116
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities.
Lunsky Y; Khuu W; Tadrous M; Vigod S; Cobigo V; Gomes T
Can J Psychiatry; 2018 Jun; 63(6):361-369. PubMed ID: 28830241
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities.
O'Dwyer C; McCallion P; Henman M; McCarron M; O'Leary E; Burke E; O'Connell J; O'Dwyer M
J Appl Res Intellect Disabil; 2019 Jul; 32(4):981-993. PubMed ID: 31038275
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials.
Brylewski J; Duggan L
J Intellect Disabil Res; 1999 Oct; 43 ( Pt 5)():360-71. PubMed ID: 10546960
[TBL] [Abstract][Full Text] [Related]
13. Safety of antipsychotics in people with intellectual disability.
Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
[TBL] [Abstract][Full Text] [Related]
14. Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
Unwin GL; Deb S
Am J Ment Retard; 2008 Jan; 113(1):19-31. PubMed ID: 18173296
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
Amore M; Bertelli M; Villani D; Tamborini S; Rossi M
J Intellect Disabil Res; 2011 Feb; 55(2):210-8. PubMed ID: 21129058
[TBL] [Abstract][Full Text] [Related]
16. Explicit review of risperidone long-acting injection prescribing practice.
Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
[TBL] [Abstract][Full Text] [Related]
18. A review of empirical evidence of somatic treatment options for the MI/DD population.
Ulzen TP; Powers RE
Psychiatr Q; 2008 Sep; 79(3):265-73. PubMed ID: 18726159
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross-sectional, epidemiological study in Germany.
Koch AD; Dobrindt J; Schützwohl M
J Intellect Disabil Res; 2021 Feb; 65(2):186-198. PubMed ID: 33393123
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
